Dr Randall Curtis Zernzach, MD in Anchorage, AK - Medicare Pediatrics

Dr Randall Curtis Zernzach, MD is a medicare enrolled "Pediatrics - Developmental - Behavioral Pediatrics" physician in Anchorage, Alaska. His current practice location is 4441 Diplomacy Dr Fl 5, Anchorage, Alaska. You can reach out to his office (for appointments etc.) via phone at (907) 729-4205.

Dr Randall Curtis Zernzach is licensed to practice in Alaska (license number 125677) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1730175662.

Contact Information

	Dr Randall Curtis Zernzach, MD
	4441 Diplomacy Dr Fl 5, Anchorage, AK 99508-5910
	(907) 729-4205
	(907) 729-8718

Physician's Profile

Full Name	Dr Randall Curtis Zernzach
Gender	Male
Speciality	Pediatrics - Developmental - Behavioral Pediatrics
Location	4441 Diplomacy Dr Fl 5, Anchorage, Alaska
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1730175662
Provider Enumeration Date: 09/26/2005
Last Update Date: 09/27/2021

Medicare PECOS Information:

PECOS PAC ID: 9931324514
Enrollment ID: I20140716000576

Medical Identifiers

Medical identifiers for Dr Randall Curtis Zernzach such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1730175662	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2080P0006X	Pediatrics - Developmental - Behavioral Pediatrics	125677 (Alaska)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Randall Curtis Zernzach allows following entities to bill medicare on his behalf.

Entity Name	Southeast Alaska Regional Health Consortium
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631

News Archive

Simple protein urine test may help detect early kidney disease in people with lupus

Simple urine tests for four proteins might be able to detect early kidney disease in people with lupus, researchers at UT Southwestern Medical Center have found in an animal study.

Longer CPAP use at night can normalize one's daytime functioning

A study published in the June 1st issue of the journal SLEEP finds that longer nightly duration of continuous positive airway pressure (CPAP) use can help those suffering from obstructive sleep apnea (OSA) achieve normal daytime functioning.

Omron releases two new pedometers with Tri-Axis technology

With summer in full effect, people are participating in outdoor activities to reach their fitness goals. Research shows that using a pedometer can increase physical activity and can be a great motivational tool to help people reach the recommended 10,000 steps a day. Today Omron Healthcare, Inc., a leader in health & wellness products, announced the release of two new pedometers, the Omron HJ-320 and HJ-321.

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Clinical Data, Inc. today announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze™, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze (apadenoson) for use as a pharmacologic stress agent in myocardial perfusion imaging (MPI), a method for detecting defects in the blood supply to the heart.

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Semafore Pharmaceuticals today announced the presentation of data demonstrating that SF1126, a novel small molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), has broad preclinical anti-tumor activity in multiple myeloma and lymphoma. Data were presented in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C.

Entity Name	Alaska Native Tribal Health Consortium
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772

Simple protein urine test may help detect early kidney disease in people with lupus

Simple urine tests for four proteins might be able to detect early kidney disease in people with lupus, researchers at UT Southwestern Medical Center have found in an animal study.

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Entity Name	Southcentral Foundation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416

Simple protein urine test may help detect early kidney disease in people with lupus

Simple urine tests for four proteins might be able to detect early kidney disease in people with lupus, researchers at UT Southwestern Medical Center have found in an animal study.

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Randall Curtis Zernzach is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Randall Curtis Zernzach, MD 4441 Diplomacy Dr Fl 5, Anchorage, AK 99508-5910 Ph: (907) 729-4205	Dr Randall Curtis Zernzach, MD 4441 Diplomacy Dr Fl 5, Anchorage, AK 99508-5910 Ph: (907) 729-4205

News Archive

Simple protein urine test may help detect early kidney disease in people with lupus

Simple urine tests for four proteins might be able to detect early kidney disease in people with lupus, researchers at UT Southwestern Medical Center have found in an animal study.

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Pediatrics Doctors in Anchorage, AK

Elizabeth Mumford Galloway, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-562-2211 Fax: 509-479-0214
Wendy Bailey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite A-351, Anchorage, AK 99508 Phone: 907-212-4824 Fax: 907-212-4831
Jay D. Johnson, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3801 Lake Otis Pkwy Ste 200, Anchorage, AK 99508 Phone: 907-212-6900
Dr. Stephen Scott Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2841 Debarr Rd, Bldg A, Suite 23, Anchorage, AK 99508 Phone: 907-677-1864 Fax: 907-868-5167
Dr. Rachel Mauryce Kerford Lescher, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508 Phone: 907-729-1000 Fax: 907-729-5244
Dr. James Monroe Nesbitt Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3200 Providence Dr, Administration Office, Anchorage, AK 99508 Phone: 907-261-5098 Fax: 907-743-2358
Dr. Emily Margaret Reilly, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-4068

Dr Randall Curtis Zernzach, MD - Medicare Pediatrics in Anchorage, AK

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Simple protein urine test may help detect early kidney disease in people with lupus

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Simple protein urine test may help detect early kidney disease in people with lupus

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Simple protein urine test may help detect early kidney disease in people with lupus

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Simple protein urine test may help detect early kidney disease in people with lupus

Longer CPAP use at night can normalize one's daytime functioning

Omron releases two new pedometers with Tri-Axis technology

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Semafore Pharmaceuticals' SF1126 PI3K-mTOR inhibitor demonstrates broad anti-tumor activity in lymphoma

Pediatrics Doctors in Anchorage, AK